Scribe Therapeutics cofounder and CEO Benjamin Oakes, PhD, joins a16z Bio + Health founding general partner Vijay Pande.
In this episode, Benjamin traces his journey from PhD student to pioneering CEO in genome editing. Benjamin discusses his early exposure to CRISPR technologies, his hands-on experience of transforming these bacterial immune systems into "genome editing scalpels," and the founding of Scribe. The conversation sheds light on the challenges of engineering these molecules, as well as the potential for life-changing therapeutics.
The Machine That Made the Vaccine
The Cost Disease in Healthcare
Journal Club: How to Win an Evolutionary Arms Race
The Google Maps Moment in (Modeling) Biology
Journal Club: Bioengineering Birth
The Story of Schizophrenia
Food as Medicine
Journal Club: Decoding Developmental Disorders
Health—at What Price?
Journal Club: Defeating Type 1 Diabetes
We, the Patients
Journal Club: Architecting an Aggressive Cancer
The Thermodynamics of Life
Journal Club: From Insect Eyes to Nanomaterials
It's Time to Build in Healthcare: COVID-19, Innovation, and What Comes Next
Journal Club: Reversing Parkinson's with New Neurons
The Biology of Pain
Journal Club: Super-Scaling COVID-19 Testing with DNA Sequencing
Biology by Design
Journal Club: Turning a Toxin into a Genome Editing Tool
Create your
podcast in
minutes
It is Free